NextCure, Inc. (NXTC) › Shareholders' EquityNextCure, Inc. (NXTC) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$24.41M2018: -$46.94M2019: $321.48M2020: $293.72M2021: $233.39M2022: $167.53M2023: $114.42M2024: $65.47M2025: $34.94M$34.94M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$34.94M-46.6%2024$65.47M-42.8%2023$114.42M-31.7%2022$167.53M-28.2%2021$233.39M-20.5%2020$293.72M-8.6%2019$321.48M+784.8%2018-$46.94M-92.3%2017-$24.41M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share